*ST賽為(300044.SZ):財務總監劉誠辭職 由石井豔接任
格隆匯7月15日丨*ST賽為(300044.SZ)公佈,公司董事會於近日收到公司財務總監劉誠的書面辭職報吿。劉誠因個人原因,向公司董事會申請辭去公司財務總監職務,但仍在公司任職。根據《公司章程》及相關規定,劉誠的辭職報吿自送達董事會之日起生效。
公司於2021年7月15日召開的第五屆董事會第十五次會議,審議並通過了《關於聘任公司財務總監的議案》,為保證公司財務工作的正常開展,經公司總經理提名,董事會提名委員會審查,董事會同意石井豔為公司財務總監,任期自本次董事會審議通過當日起至第五屆董事會任期屆滿之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.